A new type of cell therapy which could offer “real hope” to patients with advanced liver disease has been welcomed by a liver charity. Researchers said results from a clinical trial suggest that the ...
A new type of cell therapy shows promise as the first treatment for advanced liver disease, following results from a clinical trial. Patients with the condition who were treated with the cell therapy ...
Roche introduces the first comprehensive library of certified healthcare algorithms to support chronic liver disease (CLD) management The Liver Disease Panel includes LiverPRO—a certified algorithm ...
Patients with cirrhosis and obesity who undergo bariatric surgery see survival benefits over 10 years that make the surgery cost-effective compared with people who only receive a lifestyle ...
Nonalcoholic fatty liver disease (NAFLD), now reclassified as metabolic dysfunction-associated steatotic liver disease (MASLD), and its more severe form, nonalcoholic steatohepatitis (NASH), renamed ...
Roche has introduced what it says is the first comprehensive panel of certified algorithms to help manage people living with ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Patients with cirrhosis had a higher risk for post-EMR ...
The addition of SGLT2 inhibitors was associated with a nearly one third lower incidence of serious liver events in individuals with cirrhosis who were receiving diuretic therapy, a large cohort study ...
Please provide your email address to receive an email when new articles are posted on . The pharmacokinetics of survodutide were not affected by cirrhosis. The dual agonist was “generally tolerable” ...
Patients in the Phase 3 MAESTRO-NAFLD-1 trial achieved a statistically significant mean reduction of 6.7 kPa in liver stiffness, the largest reported in compensated MASH cirrhosis populations. 51% of ...
Asianet Newsable on MSN
Is liver cirrhosis irreversible? The truth about the ‘point of no return’
Cirrhosis is not a condition that can be reversed overnight, but it is also not always a fixed endpoint. With the right ...
GLP-1 drugs are often praised for their metabolic benefits, including improved blood sugar control and weight reduction. However, in patients with liver cirrhosis, these benefits may come with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results